Combination therapy: Management of acute myocardial infarction in the new millennium

David J. Moliterno

doi:10.1016/S0736-4679(00)00253-5

Combination therapy: Management of acute myocardial infarction in the new millennium

Research output: Contribution to journal › Article › peer-review

Abstract

There remains room for substantial improvement in today's reperfusion strategies. Combination therapy with fibrinolytic agents and GPIIb/IIIa antagonists appears to be a leading option available to enhance thrombolysis. However, before this strategy can be incorporated in routine practice protocols, it is necessary to define the optimal dosing and duration of therapy that will provide rapid reperfusion with minimal adverse effects.

Original language	English
Pages (from-to)	S33-S38
Journal	Journal of Emergency Medicine
Volume	19
Issue number	3 SUPPL.
DOIs	https://doi.org/10.1016/S0736-4679(00)00253-5
State	Published - 2000

ASJC Scopus subject areas

Emergency Medicine

Access to Document

10.1016/S0736-4679(00)00253-5

Cite this

@article{0479eea179d94a93a674994ce3fac47f,

title = "Combination therapy: Management of acute myocardial infarction in the new millennium",

abstract = "There remains room for substantial improvement in today's reperfusion strategies. Combination therapy with fibrinolytic agents and GPIIb/IIIa antagonists appears to be a leading option available to enhance thrombolysis. However, before this strategy can be incorporated in routine practice protocols, it is necessary to define the optimal dosing and duration of therapy that will provide rapid reperfusion with minimal adverse effects.",

author = "Moliterno, {David J.}",

year = "2000",

doi = "10.1016/S0736-4679(00)00253-5",

language = "English",

volume = "19",

pages = "S33--S38",

number = "3 SUPPL.",

}

TY - JOUR

T1 - Combination therapy

T2 - Management of acute myocardial infarction in the new millennium

AU - Moliterno, David J.

PY - 2000

Y1 - 2000

N2 - There remains room for substantial improvement in today's reperfusion strategies. Combination therapy with fibrinolytic agents and GPIIb/IIIa antagonists appears to be a leading option available to enhance thrombolysis. However, before this strategy can be incorporated in routine practice protocols, it is necessary to define the optimal dosing and duration of therapy that will provide rapid reperfusion with minimal adverse effects.

AB - There remains room for substantial improvement in today's reperfusion strategies. Combination therapy with fibrinolytic agents and GPIIb/IIIa antagonists appears to be a leading option available to enhance thrombolysis. However, before this strategy can be incorporated in routine practice protocols, it is necessary to define the optimal dosing and duration of therapy that will provide rapid reperfusion with minimal adverse effects.

UR - http://www.scopus.com/inward/record.url?scp=0033762176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033762176&partnerID=8YFLogxK

U2 - 10.1016/S0736-4679(00)00253-5

DO - 10.1016/S0736-4679(00)00253-5

M3 - Article

C2 - 11050382

AN - SCOPUS:0033762176

SN - 0736-4679

VL - 19

SP - S33-S38

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

IS - 3 SUPPL.

ER -

Combination therapy: Management of acute myocardial infarction in the new millennium

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this